[
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider",
    "summary": "In the closing of the recent trading day, Boston Scientific (BSX) stood at $102.67, denoting a +1.97% change from the preceding trading day.",
    "url": "https://finnhub.io/api/news?id=fe14a4da08b44a592300140b3939cf722777d5a720cb3ae29ccba9f31d8a339e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742853615,
      "headline": "Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider",
      "id": 133360430,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "In the closing of the recent trading day, Boston Scientific (BSX) stood at $102.67, denoting a +1.97% change from the preceding trading day.",
      "url": "https://finnhub.io/api/news?id=fe14a4da08b44a592300140b3939cf722777d5a720cb3ae29ccba9f31d8a339e"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=f05502b6086b584b3217de7f48835c5c43fb694bc8184898392fbcbd52b23508",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742834100,
      "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "id": 133363452,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=f05502b6086b584b3217de7f48835c5c43fb694bc8184898392fbcbd52b23508"
    }
  },
  {
    "ts": null,
    "headline": "Fed's Stagflation Fears Weigh, Yet Growth Factors Make BSX Stock a Buy",
    "summary": "Boston Scientific, with substantial operations in China and Europe, faces significant risks due to escalating global trade tensions in 2025.",
    "url": "https://finnhub.io/api/news?id=52a7777dd0d27d56183d359f1ffd0b685cc5ca34a30c30b684a7b4654b17df66",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742832000,
      "headline": "Fed's Stagflation Fears Weigh, Yet Growth Factors Make BSX Stock a Buy",
      "id": 133360431,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific, with substantial operations in China and Europe, faces significant risks due to escalating global trade tensions in 2025.",
      "url": "https://finnhub.io/api/news?id=52a7777dd0d27d56183d359f1ffd0b685cc5ca34a30c30b684a7b4654b17df66"
    }
  },
  {
    "ts": null,
    "headline": "Illumina's AGD Project Completes 250,000 Whole Genomes: Stock to Gain?",
    "summary": "ILMN-NashBio's AGD initiative achieves the milestone of completing 250,000 whole genomes.",
    "url": "https://finnhub.io/api/news?id=8e93777ecf5b8068922059d6d72aaf3cf1cdb0500189bd6177758b5311cd7e04",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742831220,
      "headline": "Illumina's AGD Project Completes 250,000 Whole Genomes: Stock to Gain?",
      "id": 133349527,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "ILMN-NashBio's AGD initiative achieves the milestone of completing 250,000 whole genomes.",
      "url": "https://finnhub.io/api/news?id=8e93777ecf5b8068922059d6d72aaf3cf1cdb0500189bd6177758b5311cd7e04"
    }
  },
  {
    "ts": null,
    "headline": "New Thrombectomy Product Launches Support PEN Stock Amid Macro Issues",
    "summary": "Penumbra expects to materially increase both revenues and profitability in the company's international business in the next few years.",
    "url": "https://finnhub.io/api/news?id=c83ce99035348caaae20e8a5ac1da445d15bebd6f49b1370d7c12ec5196ea67c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742830620,
      "headline": "New Thrombectomy Product Launches Support PEN Stock Amid Macro Issues",
      "id": 133349528,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Penumbra expects to materially increase both revenues and profitability in the company's international business in the next few years.",
      "url": "https://finnhub.io/api/news?id=c83ce99035348caaae20e8a5ac1da445d15bebd6f49b1370d7c12ec5196ea67c"
    }
  },
  {
    "ts": null,
    "headline": "GEHC Stock Falls Despite New Launch to Boost Breast Cancer Diagnosis",
    "summary": "GE HealthCare aims to deliver optimal outcomes with its innovative, patient-friendly and efficient AI-driven technology via its latest product offering.",
    "url": "https://finnhub.io/api/news?id=d9b56b81dce4bc9c8416dc369caa9c502b6d94bac00eaf92ef13e47dabf81de0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742827620,
      "headline": "GEHC Stock Falls Despite New Launch to Boost Breast Cancer Diagnosis",
      "id": 133349529,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "GE HealthCare aims to deliver optimal outcomes with its innovative, patient-friendly and efficient AI-driven technology via its latest product offering.",
      "url": "https://finnhub.io/api/news?id=d9b56b81dce4bc9c8416dc369caa9c502b6d94bac00eaf92ef13e47dabf81de0"
    }
  },
  {
    "ts": null,
    "headline": "BDX Shares May Climb as GalaFLEX LITE Trial Hits Key Milestone",
    "summary": "BD advances its clinical trial for the bioabsorbable GalaFLEX LITE scaffold, aiming to improve outcomes in breast implant revision surgeries and patient recovery.",
    "url": "https://finnhub.io/api/news?id=7e027c395cbe12098a9453f7a53bda9eeb4815725fd37c95cdecc4da3035c611",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742826060,
      "headline": "BDX Shares May Climb as GalaFLEX LITE Trial Hits Key Milestone",
      "id": 133349531,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BD advances its clinical trial for the bioabsorbable GalaFLEX LITE scaffold, aiming to improve outcomes in breast implant revision surgeries and patient recovery.",
      "url": "https://finnhub.io/api/news?id=7e027c395cbe12098a9453f7a53bda9eeb4815725fd37c95cdecc4da3035c611"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why You Should Hold GEHC Stock in Your Portfolio for Now",
    "summary": "GE HealthCare's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.",
    "url": "https://finnhub.io/api/news?id=842fa6a7deac2892315070577528d44397f2567bf5c3bc79c7ca62365e04cedb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742825520,
      "headline": "Here's Why You Should Hold GEHC Stock in Your Portfolio for Now",
      "id": 133349532,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "GE HealthCare's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.",
      "url": "https://finnhub.io/api/news?id=842fa6a7deac2892315070577528d44397f2567bf5c3bc79c7ca62365e04cedb"
    }
  },
  {
    "ts": null,
    "headline": "Watch These 5 AI-Powered Healthcare Bigwigs for Portfolio Gains",
    "summary": "Five AI-powered stocks have strong revenues and earnings growth potentials for 2025. These are: MDT, LLY, BSX, NVS, ABT.",
    "url": "https://finnhub.io/api/news?id=9f607916861a251ac2f38010bc94af9ad6339bdd02a60b1848572732d128835f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742820300,
      "headline": "Watch These 5 AI-Powered Healthcare Bigwigs for Portfolio Gains",
      "id": 133337771,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Five AI-powered stocks have strong revenues and earnings growth potentials for 2025. These are: MDT, LLY, BSX, NVS, ABT.",
      "url": "https://finnhub.io/api/news?id=9f607916861a251ac2f38010bc94af9ad6339bdd02a60b1848572732d128835f"
    }
  },
  {
    "ts": null,
    "headline": "Returns Are Gaining Momentum At Boston Scientific (NYSE:BSX)",
    "summary": "If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...",
    "url": "https://finnhub.io/api/news?id=8a15b296ff13f0ae4bc013c559a7c5fa1692925193d8229a01bb07632d19e6b2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742814021,
      "headline": "Returns Are Gaining Momentum At Boston Scientific (NYSE:BSX)",
      "id": 133337931,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...",
      "url": "https://finnhub.io/api/news?id=8a15b296ff13f0ae4bc013c559a7c5fa1692925193d8229a01bb07632d19e6b2"
    }
  }
]